Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
For eligible Medicare Part D members with a qualifying GLP-1 prescription for weight management.This is not a guarantee of coverage
Chem Biol Interact 2010;184:458-65
Wegovy is suitable to be prescribed by a specialist for children over the age of 12 years old however, Mounjaro is for 18 years old or older
Based on typical FDA review timelines and the current progress of trials, analysts project: Phase 3 trial completion: Late 2025 to early 2026 FDA submission: First half of 2026 Potential FDA approval: Q3 2026 to Q1 2027 Commercial availability: 2-3 months post-approval The FDA has not granted any special designations (Breakthrough Therapy, Fast Track) for Retatrutides obesity indication, which may mean standard review timelines apply
US$ 26.39
US$ 29.32
US$ 24.94
US$ 20.65
US$ 27.60
